Siren, L.L.C. Vera Therapeutics, Inc. Transaction History
Siren, L.L.C.
- $2.26 Trillion
- Q4 2024
A detailed history of Siren, L.L.C. transactions in Vera Therapeutics, Inc. stock. As of the latest transaction made, Siren, L.L.C. holds 758,465 shares of VERA stock, worth $22.5 Million. This represents 1.42% of its overall portfolio holdings.
Number of Shares
758,465
Previous 837,928
9.48%
Holding current value
$22.5 Million
Previous $37 Billion
13.39%
% of portfolio
1.42%
Previous 1.85%
Shares
2 transactions
Others Institutions Holding VERA
# of Institutions
193Shares Held
63.9MCall Options Held
68.1KPut Options Held
88.6K-
Avoro Capital Advisors LLC New York, NY5.61MShares$166 Million3.46% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.38MShares$130 Million0.02% of portfolio
-
Black Rock Inc. New York, NY3.34MShares$98.8 Million0.0% of portfolio
-
Abingworth LLP London, X02.96MShares$87.7 Million19.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.95MShares$87.3 Million0.0% of portfolio
About Vera Therapeutics, Inc.
- Ticker VERA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 27,042,300
- Market Cap $801M
- Description
- Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with ...